Targeting human TLRs to combat COVID-19: A solution?
J Med Virol
.
2021 Feb;93(2):615-617.
doi: 10.1002/jmv.26387.
Epub 2020 Aug 13.
Authors
Ritwik Patra
1
,
Nabarun Chandra Das
1
,
Suprabhat Mukherjee
1
Affiliation
1
Integrative Biochemistry & Immunology Laboratory, Department of Animal Science, Kazi Nazrul University, Asansol, West Bengal, India.
PMID:
32749702
PMCID:
PMC7436140
DOI:
10.1002/jmv.26387
No abstract available
Publication types
Letter
Comment
MeSH terms
Actin Depolymerizing Factors
CD4-Positive T-Lymphocytes
COVID-19*
Cell Movement
HIV Infections*
Humans
Immune Reconstitution*
SARS-CoV-2
Substances
Actin Depolymerizing Factors